Japan ticks Gropep mix
Thursday, 21 April, 2005
Adelaide biopharma GroPep has announced that a Japanese biopharmaceutical company has received regulatory approval in Japan to manufacture a biopharmaceutical product containing one of GroPep's products.
GroPep said commercial secrecy prevented it naming the ingredient, the company, or the product, but it is the sixth biopharmaceutical product containing GroPep's proprietary cell-culture products to receive regulatory approval.
It's not going to be a big source of revenue, but GroPep said the Japanese product is currently undergoing clinical trials for several other indications, some of which have multi-billion global markets.
CEO Bob Finder said the Japanese approval reinforced growing international recognition of the superiority of GroPep's cell culture products for the manufacture of certain biopharmaceutical products.
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
